DB19098InvestigationalSmall molecule
Pegsitacianine is under investigation in clinical trial NCT05576974 (A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection...
- Code names
- ONM-100 · ONM-100 DS
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Pegsitacianine, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account